Hong Kong stocks moving abnormally | Sinobioway Pharmacy (02096.HK) rose more than 3% as Dali Leisheng tablets were approved for sale in China for the treatment of insomnia.

According to the Securities Times app, Sinopharm Group's stock (02096.HK) has risen by over 3%, as of the time of publication, it is up by 2.17%, at 10.34 Hong Kong dollars, with a trading volume of 187 million Hong Kong dollars.